Nate Crossett

Stock Analyst at Exane BNP Paribas

(2.61)
# 2,062
Out of 4,784 analysts
38
Total ratings
53.85%
Success rate
1.9%
Average return

Stocks Rated by Nate Crossett

Medical Properties Trust
Mar 12, 2025
Upgrades: Outperform
Price Target: $5$9
Current: $6.04
Upside: +49.01%
Omega Healthcare Investors
Feb 8, 2024
Upgrades: Neutral
Price Target: $30
Current: $38.08
Upside: -21.22%
Agree Realty
Dec 13, 2023
Downgrades: Neutral
Price Target: $64
Current: $76.63
Upside: -16.48%
NETSTREIT
Dec 13, 2023
Downgrades: Neutral
Price Target: $17
Current: $15.84
Upside: +7.32%
Realty Income
Dec 13, 2023
Upgrades: Outperform
Price Target: $63
Current: $56.61
Upside: +11.29%
Alexandria Real Estate Equities
Oct 11, 2023
Initiates: Neutral
Price Target: $108
Current: $95.60
Upside: +12.97%
Ventas
Oct 11, 2023
Initiates: Outperform
Price Target: n/a
Current: $68.76
Upside: -
Digital Realty Trust
Jul 28, 2023
Upgrades: Outperform
Price Target: $138
Current: $142.10
Upside: -2.89%
Prologis
Jul 20, 2023
Upgrades: Outperform
Price Target: $141
Current: $110.45
Upside: +27.66%
Gaming and Leisure Properties
Jun 14, 2023
Initiates: Outperform
Price Target: $63
Current: $50.40
Upside: +25.00%
Initiates: Underperform
Price Target: $42
Current: $42.09
Upside: -0.21%
Initiates: Outperform
Price Target: $41
Current: $32.01
Upside: +28.08%
Initiates: Outperform
Price Target: $29
Current: $32.60
Upside: -11.04%
Initiates: Underperform
Price Target: $74
Current: $62.70
Upside: +18.02%
Initiates: Outperform
Price Target: n/a
Current: $18.10
Upside: -
Initiates: Underperform
Price Target: $9.6
Current: $8.00
Upside: +20.00%
Initiates: Outperform
Price Target: $66
Current: $85.10
Upside: -22.44%
Initiates: Outperform
Price Target: $38
Current: $21.88
Upside: +73.67%
Initiates: Outperform
Price Target: $886
Current: $803.00
Upside: +10.34%
Downgrades: Hold
Price Target: $31$30
Current: $28.58
Upside: +4.97%
Initiates: Buy
Price Target: $21
Current: $7.39
Upside: +184.17%
Downgrades: Hold
Price Target: $21$25
Current: $10.64
Upside: +134.96%
Upgrades: Buy
Price Target: n/a
Current: $25.23
Upside: -